Inventor · disambiguated record
Dahlia Weiss
Also filed as: WEISS DAHLIA · WEISS DAHLIA RUTH
9 granted patents·5 pending applications·56 citations·filing 2019–2025
87Inventor score
Top patents by PatentIndex Score
14 records- 0197US11530229B2Cyano cyclobutyl compounds for CBL-B inhibition and uses thereofNURIX THERAPEUTICS INC·Filed 2020·Granted Dec 20, 2022·12 cites·71 claims
- 0297US11464802B23-substituted piperidine compounds for Cbl-b inhibition, and use thereofNURIX THERAPEUTICS INC·Filed 2020·Granted Oct 11, 2022·14 cites·53 claims
- 0397US11401267B2Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereofNURIX THERAPEUTICS INC·Filed 2020·Granted Aug 2, 2022·11 cites·32 claims
- 0494US11951133B23-substituted piperidine compounds for Cbl-b inhibition, and use thereofNURIX THERAPEUTICS INC·Filed 2022·Granted Apr 9, 2024·2 cites·36 claims
- 0594US11866442B2Bifunctional compounds for degrading BTK via ubiquitin proteosome pathwayNURIX THERAPEUTICS INC·Filed 2022·Granted Jan 9, 2024·5 cites·37 claims
- 0693US11479556B1Bifunctional compounds for degrading BTK via ubiquitin proteosome pathwayNURIX THERAPEUTICS INC·Filed 2019·Granted Oct 25, 2022·9 cites·106 claims
- 0792US12485144B23-substituted piperidine compounds for Cbl-b inhibition, and use thereofNURIX THERAPEUTICS INC·Filed 2024·Granted Dec 2, 2025·1 cites·40 claims
- 0892US12049471B2Cyano cyclobutyl compounds for Cbl-b inhibition and uses thereofNURIX THERAPEUTICS INC·Filed 2022·Granted Jul 30, 2024·1 cites·16 claims
- 0990US12234230B2Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereofNURIX THERAPEUTICS INC·Filed 2022·Granted Feb 25, 2025·1 cites·5 claims
- 1081US2025136590A1Substituted benzyl-triazole compounds for cbl-b inhibition, and further uses thereofNURIX THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1180US2024409555A1Cyano cyclobutyl compounds for cbl-b inhibition and uses thereofNURIX THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1252US2025282786A1Tricyclic TLR7 Agonists and Uses ThereofBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 1351US2022387395A1Urea, amide, and substituted heteroaryl compounds for cbl-b inhibitionNURIX THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1445US2025282776A1Bicyclic TLR7 Agonists and Uses ThereofBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dahlia Weiss files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →